Scripps Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Scripps Health sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Scripps Health: 30 sponsored US clinical trials, 7 recruiting.
Scripps Health sponsors 30 registered US clinical trials on ClinicalTrials.gov, 7 of them currently recruiting, and 17 completed. 3 of these trials are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 2 trials.
Top-decile sponsor footprint
Scripps Health ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
17 of 21 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
30 total, page 1 of 1
Digital and Plasma Biomarkers in Delirium
NCT07694206
Diagnostic Refinement and Educational Approaches in Managing Bone Marrow Transplantation
NCT06590285
Non-Invasive Detection of Right-to-Left Cardiac Shunts
NCT07420400
TNBC Gut Microbiota During Neoadjuvant Treatment
NCT06610097
Closed Loop Spinal Cord Stimulation for Complex Regional Pain Syndrome
NCT06421350
Sleepless at Scripps: An Inpatient White Noise Study
NCT05475262
Evaluating Infrasonic Hemodynography
NCT04636892
Low Dose Vemurafenib and Rituximab in Hairy Cell Leukemia
NCT05388123
SLeep and OPioid UsE in Patients Undergoing Total Knee Arthroplasty
NCT04247646
Duloxetine Impact on Postoperative Pain Control and Outcomes
NCT05611749
Implementing Digital Health in a Learning Health System
NCT03713333
Survey on Precision Medicine and Digital Health
NCT03543631
Adverse Events Related to Low Dose Atropine
NCT05683535
PEGPH20 Plus Gemcitabine With Radiotherapy in Patients With Localized, Unresectable Pancreatic Cancer
NCT02910882
Oral vs Intravenous Acetominophen for Postoperative Pain in Minimally Invasive Gynecologic Surgery
NCT03391284
Melatonin and Sleep in Preventing Delirium in the Hospital
NCT02597231
A Non-inferiority Evaluation of a Smart-phone Based Cervical Imaging Device.
NCT05388162
SmartScope vs Standard Colposcope for the Evaluation of Cervical Dysplasia
NCT02272075
Biomarker Monitoring in TP53 Mutation Carriers
NCT02289326
Eye Movements and Reading Disabilities
NCT01860027
Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin
NCT01729559
Genotype Information and Functional Testing Study
NCT00992420
Scripps Evaluation of Antiplatelet Therapies for Intermediate Duration With the Endeavor Stent (Seaside)
NCT00963781
The MagnaSafe Registry: Determining the Risks of Magnetic Resonance Imaging (MRI) in the Presence of Pacemakers and Implantable Cardioverter Defibrillators (ICDs)
NCT00907361
Pilot Study on the Effect of High Clopidogrel Maintenance Dosing
NCT01118793
SCRIPPS V: Intracoronary Brachytherapy for Recurrent Restenosis After Multiple Drug-Eluting Stents
NCT00714545
Unrelated Donor Stem Cell Transplantation
NCT01364363
Melatonin Effects on Luteinizing Hormone
NCT00288262
Nonmyeloablative Allogeneic Transplant
NCT01272817
Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid Tumors
NCT00003269
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 4 |
| Phase 4 | 3 |
What is open in the Scripps Health pipeline
7 recruiting of 30 indexed (23% open); 17 completed (57%).
Phase mix: 3 late (III/IV) vs 6 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Scripps Health: open-pipeline peers nationwide
Peers matched on 30 registered trials and 23% open enrollment, not the therapeutic-area sidebar.
Scripps Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 trials (± recruiting share)
- Biotronik · 30 trials · 3% recruiting
- Charles Drew University of Medicine and Science · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
Sponsors near 23% open enrollment (± trial volume)
- Major Extremity Trauma Research Consortium · 23% recruiting · 30 trials
- Hugo W. Moser Research Institute at Kennedy Krieger · 23% recruiting · 73 trials
- Texas A&M University · 23% recruiting · 95 trials
- Chugai Pharmaceutical · 24% recruiting · 17 trials
Related
What to do with this Scripps Health page
30 registered trials is a research-attention snapshot, not an endorsement of Scripps Health or any single study.
- 7 of Scripps Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition Scripps Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Scripps Health pipeline card: 30 registered trials from official public datasets.Report a data error.